We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+5.38%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.64B
AUM Growth
-$53.3M
Cap. Flow
-$136M
Cap. Flow %
-5.13%
Top 10 Hldgs %
36.54%
Holding
1,168
New
94
Increased
480
Reduced
555
Closed
36

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.36M
2
SMCI icon
Super Micro Computer
SMCI
+$2.38M
3
MRNA icon
Moderna
MRNA
+$2.02M
4
COP icon
ConocoPhillips
COP
+$1.81M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.72M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$50.2M
2
MSFT icon
Microsoft
MSFT
+$20.1M
3
AVGO icon
Broadcom
AVGO
+$9.06M
4
META icon
Meta Platforms (Facebook)
META
+$6.04M
5
AMZN icon
Amazon
AMZN
+$5.57M

Sector Composition

Rank Sector Weight
1 Technology 43.4%
2 Healthcare 11.97%
3 Consumer Discretionary 10.33%
4 Communication Services 9.11%
5 Financials 5.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
101
Monster Beverage
MNST
$91.4B
$3.97M 0.15%
76,027
-7,713
-9% -$382K
DDOG icon
102
Datadog
DDOG
$87.9B
$3.91M 0.15%
34,025
-4,117
-11% -$481K
CAT icon
103
Caterpillar
CAT
$409B
$3.89M 0.15%
9,955
-2,121
-18% -$732K
NOW icon
104
ServiceNow
NOW
$102B
$3.85M 0.15%
21,540
-205
-0.9% -$33.7K
UTHR icon
105
United Therapeutics
UTHR
$26.3B
$3.81M 0.14%
10,642
-1,996
-16% -$674K
TMO icon
106
Thermo Fisher Scientific
TMO
$211B
$3.79M 0.14%
6,133
+187
+3% +$111K
PAYX icon
107
Paychex
PAYX
$40.4B
$3.76M 0.14%
28,002
-3,118
-10% -$396K
JD icon
108
JD.com
JD
$40.8B
$3.7M 0.14%
92,488
+18,447
+25% +$507K
FANG icon
109
Diamondback Energy
FANG
$57.6B
$3.65M 0.14%
21,184
-1,319
-6% -$254K
MPWR icon
110
Monolithic Power Systems
MPWR
$65.5B
$3.61M 0.14%
3,905
-536
-12% -$463K
EA icon
111
Electronic Arts
EA
$52.4B
$3.57M 0.14%
24,919
-1,635
-6% -$237K
GEHC icon
112
GE HealthCare
GEHC
$27.6B
$3.56M 0.13%
37,976
-1,407
-4% -$118K
SRPT icon
113
Sarepta Therapeutics
SRPT
$1.66B
$3.54M 0.13%
28,375
+78
+0.3% +$10.8K
AZN icon
114
AstraZeneca
AZN
$263B
$3.52M 0.13%
22,608
-1,994
-8% -$322K
INCY icon
115
Incyte
INCY
$23.5B
$3.51M 0.13%
53,037
+249
+0.5% +$15.9K
AXP icon
116
American Express
AXP
$223B
$3.49M 0.13%
12,861
+82
+0.6% +$20.4K
SLB icon
117
SLB Ltd
SLB
$77.8B
$3.47M 0.13%
82,672
-3,483
-4% -$155K
IDXX icon
118
Idexx Laboratories
IDXX
$42.9B
$3.44M 0.13%
6,809
-449
-6% -$218K
CTSH icon
119
Cognizant
CTSH
$21.5B
$3.41M 0.13%
44,203
-1,718
-4% -$128K
WFC icon
120
Wells Fargo
WFC
$261B
$3.38M 0.13%
59,863
+7,108
+13% +$402K
INSM icon
121
Insmed
INSM
$23.2B
$3.37M 0.13%
46,186
+23,166
+101% +$1.71M
NBIX icon
122
Neurocrine Biosciences
NBIX
$17.7B
$3.35M 0.13%
29,108
+4,791
+20% +$657K
EXAS
123
DELISTED
Exact Sciences
EXAS
$3.33M 0.13%
48,869
-29,720
-38% -$1.68M
KHC icon
124
Kraft Heinz
KHC
$30.4B
$3.33M 0.13%
94,734
-1,962
-2% -$67.5K
ALNY icon
125
Alnylam Pharmaceuticals
ALNY
$36.3B
$3.32M 0.13%
12,074
-2,328
-16% -$606K
3 4
5
6 7

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Profund Advisors held 1,168 positions worth $2.64B, down 2% from $2.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Profund Advisors withdrew a net $136M in Q3 2024, closing 36 positions and reducing 555 holdings. Its most notable exit was Cerevel Therapeutics Holdings, Inc. Common Stock, an estimated $1.33M position sold in full.

By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 47% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Profund Advisors opened a new position in Palantir worth $1.57M.

  • Profund Advisors's largest Q3 2024 buy was Palantir: 42,137 shares worth $1.57M.
  • Profund Advisors added most to Apple in Q3 2024, an estimated $4.36M increase.
  • Profund Advisors's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $50.2M.
  • Profund Advisors fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $1.33M.
  • Profund Advisors's ten largest holdings make up 37% of its $2.64B portfolio in Q3 2024.
  • Profund Advisors opened 94 new positions and closed 36 in Q3 2024.
  • Profund Advisors's portfolio value fell 2% quarter-over-quarter to $2.64B.

Based on Profund Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.